A study to learn how safe nurandociguat is when taken with sildenafil in men with arterial hypertension.

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-522336-14-00

Acronym

22598

Enrollment

Registered

2025-11-12

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial hypertension, Chronic Kidney Disease

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026